Urioste George de insider trades: HeartBeam (BEAT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Urioste reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | BEAT | ↓ Sell | 57,146 | $3.19 | $182K | Direct | Dec 19, 2025 (1d) |
| Sep 6, 2024 | BEAT | ↓ Sell | 1,674 | $2.34 | $4K | Direct | Sep 11, 2024 (5d) |
| Aug 30, 2024 | BEAT | ↓ Sell | 5,500 | $2.31 | $13K | Direct | Sep 4, 2024 (5d) |
| Aug 27, 2024 | BEAT | ↓ Sell | 2,194 | $2.26 | $5K | Direct | Aug 29, 2024 (2d) |
| Aug 26, 2024 | BEAT | ↓ Sell | 2,800 | $2.31 | $6K | Direct | Aug 27, 2024 (1d) |
| Sep 29, 2023 | BEAT | ↓ Sell | 5,500 | $2.06 | $11K | Direct | Oct 3, 2023 (4d) |
| Sep 28, 2023 | BEAT | ↓ Sell | 9,834 | $2.05 | $20K | Direct | Sep 29, 2023 (1d) |
| Sep 26, 2023 | BEAT | ↓ Sell | 7,393 | $2.13 | $16K | Direct | Sep 27, 2023 (1d) |
| Sep 21, 2023 | BEAT | ↓ Sell | 983 | $2.45 | $2K | Direct | Sep 22, 2023 (1d) |
| Sep 18, 2023 | BEAT | ↓ Sell | 9,269 | $2.45 | $23K | Direct | Sep 19, 2023 (1d) |
| Sep 14, 2023 | BEAT | ↓ Sell | 10,000 | $2.05 | $21K | Direct | Sep 15, 2023 (1d) |
| Nov 9, 2010 | SABA | ↓ Sell | 312 | $5.99 | $2K | Direct | Nov 10, 2010 (1d) |
| Oct 20, 2010 | SABA | ↓ Sell | 23,123 | $5.81 | $134K | Direct | Oct 22, 2010 (2d) |
| Sep 2, 2008 | MRVL | ↓ Sell | 2,677 | $14.28 | $38K | Direct | Sep 5, 2008 (3d) |
| Jun 23, 2008 | MRVL | ↓ Sell | 4,166 | $17.66 | $74K | Direct | Jun 24, 2008 (1d) |
| Jun 2, 2008 | MRVL | ↓ Sell | 10,710 | $17.37 | $186K | Direct | Jun 3, 2008 (1d) |
| Feb 28, 2006 | CHRD | ↓ Sell | 100,000 | $3.31 | $331K | Direct | Mar 1, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BEAT insiders
Open-market trades in the last 12 months
About Urioste George de's insider trades
Urioste George de is a director at HeartBeam (BEAT). Since Feb 28, 2006, Urioste has reported no open-market purchases and 17 sales worth $1.1M on SEC Form 4. In the last 12 months: 1 sale ($182K).
Their filings also include grants and awards (14 filings), option exercises (3 filings), shares withheld for taxes (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BEAT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.